Clinical Trial Update: Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating weight loss benefits of rifaximin under an intermittent fasting diet; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Bayhealth Medical Center | Conditions: Weight Loss | Phase 4 | Status: UNKNOWN